Form 4: BioAtla CFO's RSU Tax Withholding
Insider Transaction Report
BioAtla's CFO, Richard A. Waldron, reported a routine withholding of 2,371 common shares for tax obligations tied to restricted stock unit vesting.
Summary
- Richard A. Waldron, BioAtla's Chief Financial Officer, reported a transaction involving 2,371 shares of common stock.
- The transaction, dated November 30, 2025, was a withholding by BioAtla, Inc. to cover income tax and withholding obligations.
- This withholding is associated with the vesting and net settlement of previously reported restricted stock units.
- The shares were withheld at a price of $0.904 per share.
- Following this transaction, Richard A. Waldron beneficially owns 346,150 shares of BioAtla common stock, which includes shares purchased under the Issuer's ESPP.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-scheduled.
Sentiment
Score: 5
Explanation: The filing reports a routine, non-discretionary transaction related to equity compensation and tax withholding, which is neutral in terms of company performance or outlook.
Future Outlook
The filing does not contain any forward-looking statements or guidance.
Industry Context
This is a standard insider transaction report (Form 4) detailing the withholding of shares for tax purposes related to equity compensation. Such transactions are common across all industries, particularly in biotechnology companies like BioAtla, where executive compensation often includes restricted stock units.
Stakeholder Impact
- Shareholders: Minimal impact, as it's a routine tax-related transaction and not a discretionary sale by an insider. It slightly reduces the insider's direct holdings but is part of a standard compensation structure.
- Employees: Reflects standard equity compensation practices, which can be a positive for employee retention and alignment of interests.
Key Dates
| Date | Description |
|---|---|
| 11/30/2025 | Transaction Date: Shares withheld for tax obligations related to RSU vesting. |
| 12/01/2025 | Filing Date of the Statement of Changes in Beneficial Ownership. |
Keywords
BioAtla, BCAB, Richard A. Waldron, CFO, Form 4, Insider Transaction, Stock Withholding, Restricted Stock Units, Tax Obligations, Equity Compensation, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.